A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy-Reference-Cited by-同舟云学术

A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy

Published:2013-12 Issue:6 Volume:64 Page:895-902
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Zumsteg Zachary S.,Spratt Daniel E.,Pei Isaac,Zhang Zhigang,Yamada Yoshiya,Kollmeier Marisa,Zelefsky Michael J.

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer;Ganz;Ann Intern Med,2012

2. Radical prostatectomy versus observation for localized prostate cancer;Wilt;N Engl J Med,2010

3. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study;Stattin;J Natl Cancer Inst,2012

4. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

5. Time trends and local variation in primary treatment of localized prostate cancer;Cooperberg;J Clin Oncol,2010

Cited by 343 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Briganti’s 2012 nomogram is an independent predictor of prostate cancer progression in EAU intermediate-risk class: results from 527 patients treated with robotic surgery;Asian Journal of Andrology;2024-07-30

2. Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results Registry;European Urology Oncology;2024-07

3. A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in Massachusetts;Cancer;2024-06-04

4. Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era;Urologic Oncology: Seminars and Original Investigations;2024-06

5. Variation in Androgen Deprivation Therapy Use Among Men With Intermediate-Risk Prostate Cancer: Results From a Statewide Radiation Oncology Quality Consortium;International Journal of Radiation Oncology*Biology*Physics;2024-06